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**Abstract**

**Background:** Glutamatergic hypofunction is implicated in schizophrenia. Reduced presynaptic glutamatergic markers, remarkably vesicular glutamate transporter type 1 (VGLUT1) and 2 (VGLUT2) indicates glutamatergic deficit leading to cognitive impairment in schizophrenia. However, few studies in VGLUT3 have been reported. Brahmi (*Bacopa monnieri*), a traditional herbal medicine, might be a new treatment and prevention for cognitive deficit in schizophrenia by changing cerebral VGLUT3 density.

**Objective:** To study cognitive enhancement- and neuroprotective effects of Brahmi on novel object recognition task and cerebral VGLUT3 immunodensity in sub-chronic phencyclidine (PCP) rat model of schizophrernia.

**Material and Method: Cognitive enhancement effect study;** rats were assigned to three groups; **Group-1**: Control, **Group-2**: PCP-administration, **Group-3**: PCP + Brahmi. **Neuroprotective effect study;** rats were assigned to three groups; **Group-1**: Control, **Group-2**: PCP-administration, **Group-3**: Brahmi + PCP. Discrimination ratio (DR) representing cognitive ability was obtained from novel object recognition task. VGLUT3 immunodensity was measured in prefrontal cortex, striatum and cornu ammonis fields 1--3 (CA1-3) of hippocampus using immunohistochemistry.

**Results:** DR was significantly reduced in PCP group compared with control. This occurred alongside VGLUT3 reduction in prefrontal cortex, striatum and CA1-3. PCP + Brahmi showed a higher DR score compared with PCP alone and this occurred alongside a significantly increased VGLUT3 immunodensity in prefrontal cortex and striatum. Brahmi + PCP group also showed a higher DR score compared with PCP alone and this occurred alongside a significantly increased VGLUT3 immunodensity in prefrontal cortex, striatum and CA1-3.

**Conclusion:** Reduced cerebral VGLUT3 produced cognitive deficit in rats receiving PCP. Interestingly, receiving Brahmi after PCP administration can restore this cognitive deficit by increasing VGLUT3 in prefrontal cortex and striatum. Receiving Brahmi before PCP administration can also prevent cognitive impairment by elevating VGLUT3 in prefrontal cortex, striatum and CA1-3. Therefore, Brahmi could be a new frontier of restoration and prevention of cognitive deficit in schizophrenia.
